{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:35:28Z","timestamp":1794486928148,"version":"4.9.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"World Association of Infectious Diseases and Immunological Disorders grant","award":["WAidid2016_06"],"award-info":[{"award-number":["WAidid2016_06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-2040-y","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T14:02:41Z","timestamp":1566568961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Bosis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Coro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Argentiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"2040_CR1","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1097\/INF.0000000000001304","volume":"35","author":"L Toivonen","year":"2016","unstructured":"Toivonen L, Karppinen S, Schuez-Havupalo L, Teros-Jaakkola T, Vuononvirta J, Mertsola J, et al. Burden of recurrent respiratory tract infections in children: a prospective cohort study. Pediatr Infect Dis J. 2016;35:e362\u20139.","journal-title":"Pediatr Infect Dis J"},{"key":"2040_CR2","first-page":"1","volume":"4","author":"UB Schaad","year":"2016","unstructured":"Schaad UB, Esposito S, Razi CH. Diagnosis and management of recurrent respiratory tract infections in children: a practical guide. Arch Pediatr Infect Dis. 2016;4:1\u201310.","journal-title":"Arch Pediatr Infect Dis"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1179\/joc.2003.15.1.53","volume":"15","author":"N Principi","year":"2003","unstructured":"Principi N, Esposito S, Cavagna R, Bosis S, Droghetti R, Faelli N, et al. Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. J Chemother. 2003;15:53\u20139.","journal-title":"J Chemother"},{"key":"2040_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/ACI.0000000000000433","volume":"18","author":"S Esposito","year":"2018","unstructured":"Esposito S, Soto-Martinez ME, Feleszko W, Jones MH, Shen KL, Schaad UB. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. Curr Opin Allergy Clin Immunol. 2018;18:198\u2013209.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 18","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1399-3038.2007.00625.x","volume":"18","author":"M de Martino","year":"2007","unstructured":"de Martino M, Ballotti S. The child with recurrent respiratory infections: normal or not? Pediatr Allergy Immunol. 2007;18(Suppl 18):13\u20138.","journal-title":"Pediatr Allergy Immunol"},{"key":"2040_CR6","doi-asserted-by":"publisher","first-page":"1a","DOI":"10.1007\/s11908-018-0607-z","volume":"20","author":"N Principi","year":"2018","unstructured":"Principi N, Di Cara G, Bizzarri I, Isidori C, Borgia P, Mignini C, et al. Prevention of invasive pneumococcal disease: problems emerged after some years of the 13-valent pneumococcal conjugate vaccine use. Curr Infect Dis Rep. 2018;20:1a.","journal-title":"Curr Infect Dis Rep"},{"key":"2040_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/21645515.2017.1279772","volume":"14","author":"N Principi","year":"2018","unstructured":"Principi N, Esposito S. Protection of children against influenza: emerging problems. Hum Vaccin Immunother. 2018;14:750\u20137.","journal-title":"Hum Vaccin Immunother"},{"key":"2040_CR8","first-page":"627","volume":"27","author":"S Esposito","year":"2013","unstructured":"Esposito S, Musio A. Immunostimulants and prevention of recurrent respiratory tract infections. J Biol Regul Homeost Agents. 2013;27:627\u201336.","journal-title":"J Biol Regul Homeost Agents"},{"key":"2040_CR9","doi-asserted-by":"publisher","first-page":"E1065","DOI":"10.3390\/ijerph16061065","volume":"16. pii","author":"S Esposito","year":"2019","unstructured":"Esposito S, Bianchini S, Polinori I, Principi N. Impact of OM-85 given during two consecutive years to children with a history of recurrent respiratory tract infections: a retrospective study. Int J Environ Res Public Health. 2019;16. pii:E1065.","journal-title":"Int J Environ Res Public Health"},{"key":"2040_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.anai.2015.02.008","volume":"114","author":"SC Kearney","year":"2015","unstructured":"Kearney SC, Dziekiewicz M, Feleszko W. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Ann Allergy Asthma Immunol. 2015;114:364\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2040_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.intimp.2010.06.009","volume":"10","author":"WG Bessler","year":"2010","unstructured":"Bessler WG, Vor dem Esche U, Masihi N. The bacterial extract OM-85 BV. protects mice against influenza and salmonella infection. Int Immunopharmacol. 2010;10:1086\u201390.","journal-title":"Int Immunopharmacol"},{"key":"2040_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-018-0569-7","volume":"44","author":"GA Rossi","year":"2018","unstructured":"Rossi GA, Bessler W, Ballarini S, Pasquali C. Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice. Ital J Pediatr. 2018;44:112.","journal-title":"Ital J Pediatr"},{"key":"2040_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-010-0001-x","volume":"6","author":"UB Schaad","year":"2010","unstructured":"Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010;6:5\u201312.","journal-title":"World J Pediatr"},{"key":"2040_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.intimp.2017.10.032","volume":"54","author":"J Yin","year":"2018","unstructured":"Yin J, Xu B, Zeng X, Shen K. Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis. Int Immunopharmacol. 2018;54:198\u2013209.","journal-title":"Int Immunopharmacol"},{"key":"2040_CR15","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.vaccine.2014.03.055","volume":"32","author":"S Esposito","year":"2014","unstructured":"Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, et al. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014;32:2546\u201352.","journal-title":"Vaccine"},{"key":"2040_CR16","volume-title":"Feigin and Cherry\u2019s textbook of pediatric infectious diseases","author":"J Cherry","year":"2019","unstructured":"Cherry J, Demmler-Harrison G, Kaplan S, Steinbach W, Hotez P. Feigin and Cherry\u2019s textbook of pediatric infectious diseases. 8th ed. Atlanta: Elsevier; 2019.","edition":"8"},{"key":"2040_CR17","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1378\/chest.122.6.2042","volume":"122","author":"UB Schaad","year":"2002","unstructured":"Schaad UB, M\u00fctterlein R, Goffin H, BV-Child Study Group. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest. 2002;122:2042\u20139.","journal-title":"Chest"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1097\/INF.0b013e318255dc5b","volume":"31","author":"S Esposito","year":"2012","unstructured":"Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78\u201385.","journal-title":"Pediatr Infect Dis J"},{"key":"2040_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1055\/s-0037-1617412","volume":"39","author":"PAB Wark","year":"2018","unstructured":"Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW. Respiratory viruses and asthma. Semin Respir Crit Care Med. 2018;39:45\u201355.","journal-title":"Semin Respir Crit Care Med"},{"key":"2040_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jaci.2010.07.038","volume":"126","author":"CH Razi","year":"2010","unstructured":"Razi CH, Harmanc\u0131 K, Abac\u0131 A, \u00d6zdemir O, H\u0131zl\u0131 S, Renda R, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010;126:763\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"2040_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0149-2918(00)90008-0","volume":"22","author":"JV Jara-P\u00e9rez","year":"2000","unstructured":"Jara-P\u00e9rez JV, Berber A. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin Ther. 2000;22:748\u201359.","journal-title":"Clin Ther"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3399\/bjgp14X682561","volume":"64","author":"LJ Shallcross","year":"2014","unstructured":"Shallcross LJ, Davies DS. Antibiotic overuse: a key driver of antimicrobial resistance. Br J Gen Pract. 2014;64:604\u20135.","journal-title":"Br J Gen Pract"},{"key":"2040_CR23","doi-asserted-by":"publisher","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","volume":"6","author":"A Versporten","year":"2018","unstructured":"Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6:e619\u201329.","journal-title":"Lancet Glob Health"},{"key":"2040_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/INF.0000000000000652","volume":"34","author":"JA Bielicki","year":"2015","unstructured":"Bielicki JA, Lundin R, Sharland M, ARPEC Project. Antibiotic resistance prevalence in routine bloodstream isolates from children\u2019s hospitals varies substantially from adult surveillance data in Europe. Pediatr Infect Dis J. 2015;34:734\u201341.","journal-title":"Pediatr Infect Dis J"},{"key":"2040_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ebch.1833","volume":"7","author":"BE Del-Rio-Navarro","year":"2012","unstructured":"Del-Rio-Navarro BE, Espinosa-Rosales FJ, Flenady V, Sienra-Mongen JJL. Immunostimulants for preventing respiratory tract infection in children. Evid Based Child Health. 2012;7:629\u2013717.","journal-title":"Evid Based Child Health"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-2040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-2040-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-2040-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T23:14:46Z","timestamp":1598051686000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-2040-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-2040-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy (no. 418_2016bis), and written informed consent was obtained from all the participants\u2019 parents or legal guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all the participants\u2019 parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"284"}}